Skip to main content
. 2020 Oct 13;40(10):BSR20201349. doi: 10.1042/BSR20201349

Figure 5. Cell viability test of active compounds of TXL.

Figure 5

(A) Different concentrations of active compounds on improvement rate (n=5). (B) Exploration of optimal dosage of active compounds on improvement rate (n=5). * indicates existence of significance (P<0.05).